Manufacturer assistance programs, including free or replacement drug and copay assistance programs, are an important tool in a cancer program’s toolbox of financial advocacy interventions, however cancer programs expend considerable time and resources navigating patients through lengthy eligibility and application processes. Access ACCC’s Policy Brief on Improving Manufacturer Financial Assistance for People with Cancer to learn how ACCC is advocating for application and process improvements to manufacturer-based assistance programs to increase access to critical financial assistance for patients.
Understanding current trends in oncology financial advocacy programs can offer valuable insight and best practices for member programs. Access ACCC’s Financial Advocacy Network 2023 Census Survey Results to explore workforce and technology trends, current practices in financial distress screening, metrics to measure program impact, and much more.
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
